![Half of Public Has Heard Little or Nothing About the New COVID-19 Booster Aimed at Omicron; Many Don't Know If the CDC Recommends That They Get the New Booster | KFF Half of Public Has Heard Little or Nothing About the New COVID-19 Booster Aimed at Omicron; Many Don't Know If the CDC Recommends That They Get the New Booster | KFF](https://www.kff.org/wp-content/uploads/2022/09/Fig-3-a-third-of-adults-have-gotten-or-will-get-updated-booster.png)
Half of Public Has Heard Little or Nothing About the New COVID-19 Booster Aimed at Omicron; Many Don't Know If the CDC Recommends That They Get the New Booster | KFF
![CDC on X: "The updated bivalent #COVID19 boosters help restore protection that has decreased since previous vaccination and provide broader protection against the newer BA.4 and BA.5 variants. To search for a CDC on X: "The updated bivalent #COVID19 boosters help restore protection that has decreased since previous vaccination and provide broader protection against the newer BA.4 and BA.5 variants. To search for a](https://pbs.twimg.com/media/FcuZrNrXoAUhCHQ.jpg)
CDC on X: "The updated bivalent #COVID19 boosters help restore protection that has decreased since previous vaccination and provide broader protection against the newer BA.4 and BA.5 variants. To search for a
![Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health](https://publichealth.jhu.edu/sites/default/files/styles/article_feature/public/2023-02/bivalent-vaccine-g1422104879.jpg?h=f7026c63&itok=62rHr_a_)
Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health
![Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ... Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e1_BivalentVECurrentSublineages_IMAGE_25Jan2023_1200x675-medium.jpg?_=95835)
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
![FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN](https://media.cnn.com/api/v1/images/stellar/prod/230109124641-moderna-bivalent-vaccine.jpg?c=original)
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
![CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News](https://i.abcnewsfe.com/a/8751bb25-b566-4440-9e9c-72099e9696bf/covid-2-rt-bb-230906_1694012668027_hpEmbed_3x2.jpg)
CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News
![Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC) Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)](https://publichealthcollaborative.org/wp-content/uploads/2022/10/ENG_Twitter_updated-booster-doses-2.png)